Regulation of α-fetoprotein by nuclear factor-κB protects hepatocytes from tumor necrosis factor-α cytotoxicity during fetal liver development and hepatic oncogenesis

Cancer Research

Volumn 64, Issue 19, 2004, Pages 7030-7038

  Cavin, Lakita G ^a   Venkatraman, Manickam ^a   Factor, Valentina M ^b   Kaur, Swayamjot ^a   Schroeder, Insa ^b   Mercurio, Frank ^c   Beg, Amer A ^d   Thorgeirsson, Snorri S ^b   Arsura, Marcello ^a,e  

^a UNIVERSITY OF TENNESSEE CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CELGENE CORPORATION   (United States)

^d Columbia University ^*  (United States)

^e UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; I KAPPA B; I KAPPA B 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL XL; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; GENE DISRUPTION; GENE EXPRESSION; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER DEVELOPMENT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ALPHA-FETOPROTEINS; ANIMALS; ANTIGENS, CD; APOPTOSIS; BCL-X PROTEIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEPATOCYTES; I-KAPPA B KINASE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, TRANSGENIC; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR-ALPHA; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 4944259394     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1647     Document Type: Article

References (37)

1. Kucharczak J, Simmons MJ, Fan Y, Gelinas C. To be, or not to be: NF-κB is the answer: role of Rel/NF-κB in the regulation of apoptosis. Oncogene 2003;22:8961-82.
2. Ghosh S, Karin M. Missing pieces in the NF-κB puzzle. Cell 2002;109(Suppl): S81-96.
3. Li ZW, Chu W, Hu Y, et al. The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis. J Exp Med 1999;189:1839-45.
4. Tanaka M, Fuentes ME, Yamaguchi K, et al. Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-κ-deficient mice. Immunity 1999;10:421-9.
5. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 1999;284:321-5.
6. Rudolph D, Yeh WC, Wakeham A, et al. Severe liver degeneration and lack of NF-κB activation in NEMO/IKKγ-deficient mice. Genes Dev 2000;14:854-62.
7. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995;376:167-70.
8. Doi TS, Marino MW, Takahashi T, et al. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci USA 1999;96:2994-9.
9. Rosenfeld ME, Prichard L, Shiojiri N, Fausto N. Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice. Am J Pathol 2000;156:997-1007.
10. Alcamo E, Mizgerd JP, Horwitz BH, et al. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-κB in leukocyte recruitment. J Immunol 2001;167:1592-600.
11. Factor V, Oliver AL, Panta GR, Thorgeirsson SS, Sonenshein GE, Arsura M. Roles of Akt/PKB and IKK complex in constitutive induction of NF-κB in hepatocellular carcinomas of transforming growth factor α/c-myc transgenic mice. Hepatology 2001;34:32-41.
12. Arsura M, Mercurio F, Oliver AL, Thorgeirsson SS, Sonenshein GE. Role of the IκB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells. Mol Cell Biol 2000;20:5381-91.
13. Romieu-Mourez R, Kim DW, Shin SM, et al. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol Cell Biol 2003;23:5738-54.
14. Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Traish AM, Mercurio F, Sonenshein GE. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-κB in breast cancer. Cancer Res 2001;61:3810-8.
15. Biswas DK, Cruz AP, Gansberger E, Pardee AB. Epidermal growth factor-induced nuclear factor κB activation: a major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sci USA 2000;97:8542-7.
16. Tai DI, Tsai SL, Chen YM, et al. Activation of nuclear factor κB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 2000;31:656-64.
17. Waris G, Livolsi A, Imbert V, Peyron JF, Siddiqui A. Hepatitis C virus NS5A and subgenomic replicon activate NF-κB via tyrosine phosphorylation of IκBα and its degradation by calpain protease. J Biol Chem 2003;278:40778-87.
18. Greten FR, Karin M. The IKK/NF-κB activation pathway: a target for prevention and treatment of cancer. Cancer Lett 2004;206:193-9.
19. Arsura M, Panta GR, Bilyeu JD, et al. Transient activation of NF-κB through a TAK1/IKK kinase pathway by TGF-β1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Oncogene 2003;22:412-25.
20. Murakami H, Sanderson ND, Nagy P, Marino PA, Merlino G, Thorgeirsson SS. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor α in hepatic oncogenesis. Cancer Res 1993;53:1719-23.
21. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT. TGF α overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990;61:1137-46.
22. Samoni-Rugiu E, Jensen MR, Thorgeirsson SS. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-inyc and transforming growth factor α. Cancer Res 1998;58:123-34.
23. Factor VM, Kiss A, Woitach JT, Wirth PJ, Thorgeirsson SS. Disruption of redox homeostasis in the transforming growth factor-α/c-myc transgenic mouse model of accelerated hepatocarcinogenesis. J Biol Chem 1998;273:15846-53.
24. Factor VM, Laskowska D, Jensen MR, Woitach JT, Popescu NC, Thorgeirsson SS. Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. Proc Natl Acad Sci USA 2000;97:2196-201.
25. Conte D, Liston P, Wong JW, Wright KE, Korneluk RG. Thymocyte-targeted overexpression of xiap transgene disrupts T lymphoid apoptosis and maturation. Proc Natl Acad Sci USA 2001;98:5049-54.
26. Arsura M, Wu M, Sonenshein GE. TGF β1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: transcriptional activation of I κB α. Immunity 1996;5:31-40.
27. Duyao MP, Buckler AJ, Sonenshein GE. Interaction of an NF-κB-like factor with a site upstream of the c-myc promoter. Proc Natl Acad Sci USA 1990;87:4727-31.
28. Shiraki K, Sugimoto K, Yamanaka Y, et al. Overexpression of X-linked inhibitor of apoptosis in human hepatocellular carcinoma. Int J Mol Med 2003;12:705-8.
29. Garcia EJ, Lawson D, Cotsonis G, Cohen C. Hepatocellular carcinoma and markers of apoptosis (bcl-2, bax, bcl-x): prognostic significance. Appl Immunohistochem Mol Morphol 2002;10:210-7.
30. Takehara T, Liu X, Fujimoto J, Friedman SL, Takahashi H. Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology 2001;34:55-61.
31. Mizejewski GJ. Biological role of α-fetoprotein in cancer: prospects for anticancer therapy. Expert Rev Anticancer Ther 2002;2:709-35.
32. Passegue E, Jochum W, Behrens A, Ricci R, Wagner EF. JunB can substitute for Jun in mouse development and cell proliferation. Nat Genet 2002;30:158-66.
33. Semenkova LN, Dudich EI, Dudich IV, Shingarova LN, Korobko VG. α-Fetoprotein as a TNF resistance factor for the human hepatocarcinoma cell line HepG2. Tumour Biol 1997;18:30-40.
34. Spear BT. α-Fetoprotein gene regulation: lessons from transgenic mice. Semin Cancer Biol 1999;9:109-16.
35. Abelev GI, Eraiser TL. Cellular aspects of α-fetoprotein reexpression in tumors. Semin Cancer Biol 1999;9:95-107.
36. Tomasi TB Jr. Structure and function of α-fetoprotein. Annu Rev Med 1977;28:453-65.
37. Gabant P, Forrester L, Nichols J, et al. α-Fetoprotein, the major fetal serum protein, is not essential for embryonic development but is required for female fertility. Proc Natl Acad Sci USA 2002;99:12865-70.